3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Multiple Myeloma
420
Precursor Cell Lymphoblastic Leukemia-Lymphoma
126
Neoplasms, Plasma Cell
74
Recurrence
70
Lymphoma
57
Leukemia
54
Neoplasms
46
Immunoglobulin Light-chain Amyloidosis
38
Burkitt Lymphoma
37
Vomiting
36
Lymphoma, Mantle-Cell
32
Lymphoma, Large B-Cell, Diffuse
31
Nausea
29
Lymphoma, Non-Hodgkin
28
Breast Neoplasms
22
Waldenstrom Macroglobulinemia
21
Lymphoma, Follicular
21
Hodgkin Disease
21
Leukemia, Lymphocytic, Chronic, B-Cell
20
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Neoplasm Metastasis
17
Prostatic Neoplasms
16
Lymphoma, Extranodal NK-T-Cell
16
Amyloidosis
16
Leukemia, Myeloid, Acute
15
Smoldering Multiple Myeloma
14
Lymphoma, B-Cell, Marginal Zone
13
Lung Neoplasms
11
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, B-Cell
10
Interventions
Gemcitabine
8
pembrolizumab
5
Cisplatin
5
enfortumab vedotin
3
avelumab
3
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Carboplatin
3
vinflunine
2
Radiotherapy
2
Nephroureterectomy
2
Immunoglobulin G
2
Doxorubicin
2
Disulfides
2
vandetanib
1
tremelimumab
1
tocilizumab
1
tamibarotene
1
relatlimab
1
pegfilgrastim
1
merphos
1
guadecitabine
1
genexol-PM
1
enzalutamide
1
durvalumab
1
dehydroftorafur
1
atezolizumab
1
abexinostat
1
Vitamin D
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Ureteral Neoplasms
×
Dexamethasone
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled